Back to catalog
FGFR3Rare
Erdafitinib
4.9 / 5High PurityPharma GradeLab TestedResearch Only
Erdafitinib is a pan-FGFR tyrosine kinase inhibitor researched for FGFR-driven tumor proliferation and urothelial carcinoma signaling. Laboratory studies map receptor autophosphorylation blockade, downstream MAPK attenuation, and selectivity across FGFR isoforms.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
ERD1G
Peptide1g powder
$180
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord